Press Releases

May 8, 2026

Derek Hwang

Press Releases

ENvue Medical Adds to Intellectual Property Portfolio by Securing USPTO Notice of Allowance for Ultrasound-Enhanced Cannabinoid Drug Delivery Technology

ENvue Medical announced that the USPTO has issued a Notice of Allowance for a patent covering its novel drug delivery system that uses proprietary surface acoustic wave (SAW) ultrasound technology to enhance transdermal delivery of cannabinoid-based therapeutics. The patent covers multiple components of the combined SAW ultrasound and cannabinoid t…

FEED

May 8, 2026

Leila Farooq

Press Releases

Alpha Tau to Host Conference Call to Discuss Interim Results from First Three Patients Treated for Recurrent Glioblastoma

Alpha Tau Medical announced a conference call scheduled for May 11, 2026, to discuss interim clinical results from the first three patients treated with its alpha-radiation therapy Alpha DaRT in a U.S. trial for recurrent glioblastoma. The trial aims to evaluate the safety and feasibility of the treatment in up to ten patients with inoperable recur…

DRTS

May 8, 2026

Caleb Monroe

Press Releases

IP Strategy Highlights Poseidon’s Launch of Numo, Expanding Supply of Rights-Cleared AI Training Data on Story

IP Strategy Holdings, Inc. announced the early access launch of Numo, a consumer app developed by Poseidon for collecting real-world, rights-cleared AI training data. By incentivizing users to contribute voice recordings across underrepresented languages and embedding licensing and provenance on-chain through the Story blockchain, Numo addresses a …

IPST

May 8, 2026

Nina Shah

Press Releases

Philips shareholders approve all proposals at the AGM 2026

Royal Philips announced that its shareholders approved all proposals at the Annual General Meeting (AGM) 2026, including the appointment of John DeFord to the Supervisory Board, re-appointments of key board members including CEO Roy Jakobs, and discharge of board members. The company maintains strong leadership continuity and expresses confidence i…

PHG

May 8, 2026

Priya Menon

Press Releases

embecta to Participate at the 2026 BofA Securities Global Health Care Conference

Embecta Corp., a global medical supplies company focused on insulin delivery innovations, announced its upcoming presentation at the 2026 BofA Securities Global Health Care Conference in Las Vegas on May 13, 2026. The company's management will discuss its current initiatives and future outlook, with a live webcast available for investors.

EMBC

May 8, 2026

Caleb Monroe

Press Releases

BioAge Labs Reports First Quarter 2026 Financial Results and Provides Business Updates

BioAge Labs announced positive Phase 1 topline data for BGE-102, an oral NLRP3 inhibitor showing significant reductions in inflammatory biomarkers related to cardiovascular risk. The company plans to initiate Phase 2 cardiovascular and Phase 1b/2a diabetic macular edema (DME) proof-of-concept trials in mid-2026, supported by $132.3 million gross pr…

BIOA

May 8, 2026

Leila Farooq

Press Releases

E-Power Awarded Government Grant to Accelerate Innovation about Carbon-Based Anode Material

E-Power Inc. announced that its subsidiary, Sunrise New Energy, received a $294,000 grant from the Guizhou Provincial Development and Reform Commission to support the establishment of the Guizhou Carbon-Based Anode Material Industrial Technology Engineering Center. This initiative aims to foster collaboration and innovation in battery anode materia…

EPOW

May 8, 2026

Maya Rios

Press Releases

J-Star Holding Signs MOU with White Group to Advance Financing for Texas Solid-State Battery Facility

J-Star Holding announced signing a non-binding MOU with Singapore-based White Group to advance capital formation for a $100 million automated solid-state battery production facility in Baytown, Texas. This initiative builds on existing partnerships and grant applications aimed at producing 100 MWh modular battery lines targeting UAV and drone marke…

YMAT

May 8, 2026

Maya Rios

Press Releases

VIVAKOR ANNOUNCES CLOSING OF $12 MILLION INSTITUTIONAL OFFERING

Vivakor, Inc. has completed a $12 million private placement of six-month convertible promissory notes with institutional investors. The proceeds will be used to reduce outstanding debt, support working capital, advance the commissioning of its Remediation Processing Center in Houston, and execute its integrated infrastructure and commercial platfor…

VIVK

May 8, 2026

Leila Farooq

Press Releases

Verizon to Speak at Upcoming Investor Conferences

Verizon Communications Inc. announced that CEO Dan Schulman will speak at two prominent investor conferences in May 2026 — the MoffettNathanson Media, Internet & Communications Conference and the J.P. Morgan Global Technology, Media, and Communications Conference. Both sessions will be webcast and available to investors via Verizon's investor relat…

VZ

May 8, 2026

Maya Rios

Press Releases

United-Guardian Reports First Quarter Results

United-Guardian, Inc. (NASDAQ:UG) announced robust financial results for Q1 2026, with sales rising to $2.87 million from $2.48 million in the previous year and net income increasing to $818,902 from $560,895. Growth was mainly driven by a 24% increase in pharmaceutical sales, particularly Renacidin®, and a 21% rise in cosmetic ingredient sales, su…

UG

May 8, 2026

Marcus Reed

Press Releases

Alpha Tau Completes Patient Enrollment in its U.S. Pivotal Skin Cancer Study, Advancing Towards Goal of FDA Approval of Alpha DaRT® to Treat Recurrent Cutaneous Squamous Cell Carcinoma

Alpha Tau Medical Ltd. has completed enrollment of all 88 patients in its ReSTART pivotal U.S. clinical trial evaluating its novel alpha-radiation therapy, Alpha DaRT, for recurrent cutaneous squamous cell carcinoma (cSCC). This milestone marks a critical step toward potential FDA pre-market approval (PMA), building on previous clinical evidence fr…

DRTS

May 8, 2026

Hana Yamamoto

Press Releases

European Wax Center Announces Completion of Take-Private by General Atlantic

European Wax Center, Inc., a leading U.S. franchisor and operator of out-of-home waxing services, has completed its take-private transaction by General Atlantic for an enterprise value of approximately $640 million. This transaction involved General Atlantic acquiring all remaining outstanding shares, leading to the delisting of European Wax Center…

EWC

May 8, 2026

Hana Yamamoto

Press Releases

Allarity Therapeutics CEO to Present at Precision Medicine Forum Europe 2026 in Stockholm

Allarity Therapeutics announced that CEO Thomas Jensen will present at Precision Medicine Forum Europe 2026 on their investigational drug stenoparib, a dual PARP and WNT pathway inhibitor in Phase 2 trials for ovarian and small cell lung cancers. The presentation will highlight the drug's unique mechanism and the company's predictive biomarker, the…

ALLR

May 8, 2026

Maya Rios

Press Releases

Moleculin Biotech Secures Strategic Additional Patent, Strengthening Global Positioning of Annamycin

Moleculin Biotech, Inc. has secured an additional patent in Hong Kong for its liposomal Annamycin formulation, extending intellectual property protection through 2040. This milestone enhances the company's global exclusivity strategy as it approaches the release of Phase 3 clinical data for Annamycin, a lead oncology drug candidate. The patent comp…

MBRX

May 8, 2026

Nina Shah

Press Releases

Gencor Releases Second Quarter Fiscal 2026 Results

Gencor Industries announced its second quarter fiscal 2026 results with net revenues declining to $33.8 million from $38.2 million year-over-year, primarily due to delayed asphalt plant orders. Despite the revenue drop, gross profit margins improved by 200 basis points to 31.7%, driven by strong manufacturing execution and cost management. Operatin…

GENC

May 8, 2026

Sofia Navarro

Press Releases

AIM ImmunoTech, Inc. Announces Exercise of Warrants for Approx. $4.2 Million in Gross Proceeds

AIM ImmunoTech, a late-stage biotech company focused on cancer treatment, announced the exercise of multiple classes of warrants by accredited investors, resulting in gross proceeds of about $4.2 million. The funds will be used primarily for working capital and general corporate purposes. Additionally, investors exchanging warrants will receive new…

AIM

May 8, 2026

Derek Hwang

Press Releases

Netcapital Inc. Announces Strategic Shift

Netcapital Inc. announced a strategic shift from a transaction-based capital formation marketplace to a data-driven capital markets infrastructure platform. Under new CEO Todd Violette, the company will leverage its proprietary dataset derived from private capital campaigns to develop or acquire AI-powered tools aimed at improving fundraising succe…

NCPL

May 8, 2026

Priya Menon

Press Releases

Stran & Company Schedules First Quarter 2026 Financial Results and Business Update Conference Call

Stran & Company, a leading outsourced marketing solutions provider specializing in promotional products and loyalty incentive programs, will host a conference call on May 13, 2026, to discuss its first quarter 2026 financial results and corporate developments. The company serves many Fortune 500 clients and emphasizes long-term relationships throug…

SWAG

May 8, 2026

Avery Klein

Press Releases

Draganfly Flex FPV Drone Selected by Two Additional U.S. Department of War Units

Draganfly Inc. has been selected by two additional U.S. Department of War units to supply its Flex FPV drone systems, highlighting increasing demand for mission-ready, rapidly deployable drones across defense applications. This selection reflects confidence in Draganfly's drone capabilities to enhance tactical operations and support defense readine…

DPRO

May 8, 2026

Marcus Reed

Press Releases

Arbor Realty Trust Reports First Quarter 2026 Results and Declares Dividend of $0.17 per Share

Arbor Realty Trust, Inc. (NYSE: ABR) reported first quarter 2026 results showing a significant decline in net income and distributable earnings compared to Q1 2025, while declaring a quarterly cash dividend of $0.17 per share. The company highlighted its large servicing and structured loan portfolios, generated additional liquidity through a collat…

ABR

May 8, 2026

Hana Yamamoto

Press Releases

CG Oncology Reports First Quarter 2026 Financial Results and Provides Business Updates

CG Oncology announced its Q1 2026 financial results, highlighting a robust cash position of $1.1 billion to fund operations through 2029 and progress toward key regulatory and clinical milestones. The company is on track to complete its Biologics License Application (BLA) submission for cretostimogene in Q4 2026 after alignment discussions with the…

CGON

May 8, 2026

Maya Rios

Press Releases

Aclaris Therapeutics to Participate in the 2026 Bank of America Healthcare Conference

Aclaris Therapeutics, a clinical-stage biopharmaceutical company, announced it will participate in the 2026 Bank of America Healthcare Conference where its President and COO will present the company's pipeline and developments. The presentation will be webcast live and archived for investor access.

ACRS

May 8, 2026

Hana Yamamoto

Press Releases

Rush Street Interactive to Participate at the 21st Annual Needham Technology, Media, & Consumer Conference

Rush Street Interactive, a leading US online casino and sports betting operator, announced its management team will participate in a fireside chat at the 21st Annual Needham Technology, Media, & Consumer Conference. The company operates in 15 US states and several international markets, leveraging its proprietary gaming platform and strong industry…

RSI

May 8, 2026

Avery Klein

Press Releases

Skycorp to Hold Extraordinary General Meeting

Skycorp Solar Group Limited, a Nasdaq-listed solar PV product provider specializing in solar cables and connectors, has announced an extraordinary general meeting to be held on June 10, 2026, at its Ningbo, China executive office. The meeting is aimed at engaging shareholders on important corporate matters, with detailed notices available on the co…

PN